ACIP Provides Recommendations on Meningococcal Vaccination
Vaccination with MenACWY recommended for adolescents aged 11 to 12 years with booster at 16 years
Once-Weekly Insulin Icodec Promising for Type 2 Diabetes
In phase 2 study, glucose-lowering efficacy, safety profile similar to once-daily insulin glargine U100
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Diagnoses of Common Conditions Declined in March to May 2020
Common mental health diagnoses reduced 50 percent; similar drops seen in circulatory system diseases, T2DM
FDA Requiring Labeling Changes to Benzodiazepine Prescribing Information
Update to Boxed Warning must include risks for abuse, misuse, addiction, physical dependence, withdrawal reaction
Guidelines Updated for Managing Dyslipidemia to Cut CVD Risk
Moderate-dose statin therapy recommended for patients with 10-year CVD risk ≥12 percent
Cognition-Enhancing Supplements May Contain Unapproved Drugs
Five unapproved pharmaceutical drugs ID'd in supplements marketed to improve memory, cognition
Teens’ Mental Illness Treatment May Not Follow Guidelines
Variance in treatment occurs within and across ZIP codes, suggesting non-supply-side variables
Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors
Risks for MACE, MI, cardiovascular death, heart failure, all-cause mortality lower versus DPP-4 inhibitors
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
If it passes final round of human tests, SinoVac will apply to the FDA to sell CoronaVac vaccine
